Systemic sclerosis-associated pulmonary arterial hypertension
about
Clinical Phenotype of Endothelial Dysfunction in a Lot of Romanian Scleroderma Patients.Clinical Phenotype of Endothelial Dysfunction in Romanian Scleroderma Patients.Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular functionEverolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial.Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patientsLung involvement in systemic sclerosis.Connective tissue disease-associated pulmonary arterial hypertension.Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patientsSubspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.The frequency of pulmonary hypertension in patients with juvenile scleroderma.The right ventricle: biologic insights and response to disease: updated.Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.Scleroderma-related lung disease: are adipokines involved pathogenically?Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathwaysThe role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.Update on pulmonary vascular diseases 2010.Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension.The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic Sclerosis.Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension.A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis.Classification and diagnosis of pulmonary hypertension.Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.Right Ventricle Remodeling and Function in Scleroderma Patients.Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survivalSystemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies
P2860
Q33572381-02B2D4F7-9D6B-4F0B-B74D-EF93BFFC8336Q33572573-B1C74AFD-791D-4A72-AE72-879B2617721DQ33806077-1DEAB58F-266D-4BE5-A005-681E0934888FQ33806121-E23A7E14-2985-42BC-B0D0-C249B7E5C9D6Q34251071-EA2D4F1A-1F6E-47EF-A051-3F7551ABFE34Q34732817-7AED73FA-00DE-45DF-B55D-A0CF0AA71A73Q35029607-1F905149-880C-4070-8286-40132BF2DD34Q35644221-EED39B86-A7A1-40B4-A35E-0B1EDA45F225Q36060142-414FED0B-5E2F-4403-A0DF-2AB2ADE8C053Q36402294-E8C6942A-C5EA-44E9-A2A1-D32A9EF629BEQ36644859-82AC09EE-9C1C-4ECF-885C-1039BBDB5F10Q36795578-1B2D8D7F-B5AB-4C1D-8234-9E087186A7BCQ36888302-3FCF7402-8C50-434A-A1E9-35F79AD9C8CDQ37345940-8D321D52-8CA0-46F6-8CB6-6EB50F892F90Q37408223-47770388-E665-4FCE-B7E8-23213D2FDC34Q37620501-32DD75D5-2083-4A33-B81E-8FD07A4F5F26Q37851851-6E5C8C3F-7BCD-4FE5-8448-972F6238957EQ37898899-2D4B1F31-DB0A-4544-B380-7AE99F42ECAFQ38112387-8B51AF4B-6AEA-4469-AB1B-19177F5976EAQ38317794-9F187240-B7B5-4FA9-9346-F1C96A29670CQ38730172-A7A3AF66-0033-4F80-8684-9A1D30AEC149Q40814361-815928E0-0F10-4ED4-B713-69FD3C176420Q41435645-F8DAEADD-73C2-4672-B7BB-29EFDCF5F611Q48179384-450FD5CF-71FA-4BEE-A911-A2CF9B754E5AQ50786421-192C63FB-EC44-4B20-AE20-D2E10E1B6B6BQ54957551-5AEBC80A-9AF4-4EFE-93C7-6A107A52C795Q55153213-7F1BA4F2-A0B6-494B-A3C7-4359C49DA8D5Q56978019-46CD7D47-F2BE-4B61-8FD9-A1C607CF0810Q56978031-EF50909A-619F-44F9-BB02-7EDA90C82D65
P2860
Systemic sclerosis-associated pulmonary arterial hypertension
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Systemic sclerosis-associated pulmonary arterial hypertension
@ast
Systemic sclerosis-associated pulmonary arterial hypertension
@en
type
label
Systemic sclerosis-associated pulmonary arterial hypertension
@ast
Systemic sclerosis-associated pulmonary arterial hypertension
@en
prefLabel
Systemic sclerosis-associated pulmonary arterial hypertension
@ast
Systemic sclerosis-associated pulmonary arterial hypertension
@en
P2860
P1476
Systemic sclerosis-associated pulmonary arterial hypertension
@en
P2093
Luc Mouthon
Paul M Hassoun
P2860
P304
P356
10.1164/RCCM.200909-1331PP
P407
P577
2010-03-01T00:00:00Z